Prostate Cancer - Apr 5, 2024 - Eating soy products linked to lower cancer risk, study finds

Can't see this email? View it online

	Prostate Cancer
	The latest prostate cancer news from News Medical

	Eating soy products linked to lower cancer risk, study finds Soy product consumption, particularly tofu and soymilk, is linked to a reduced risk of certain cancers, highlighting the dietary factor's potential protective effect against the disease.

	The efficacy of the Mediterranean diet on health outcomes in adults with cancer A new study published in Nature explores the safety and benefits of this diet in adults with cancer, in addition to its feasibility in this population.

			Revolutionizing prostate cancer diagnostics with 3D pathology and deep learning Prostate cancer stands as a prevalent threat to men's health, ranking second in cancer-related deaths in the United States.

			Lancet report highlights the future landscape of prostate cancer Annual prostate cancer cases worldwide are projected to double by the year 2040, and annual deaths are projected to increase by 85% to almost 700,000 over the same timeframe – mainly among men in low- and middle-income countries.

			Relugolix and radiation therapy may be a safe, effective combination for treating prostate cancer A high impact study led by Daniel Spratt, M.D., Vincent K. Smith Chair in Radiation Oncology at University Hospitals Seidman Cancer Center demonstrates the safety and efficacy of a novel oral hormone therapy, relugolix, in conjunction with radiation therapy for treating men with localized and advanced prostate cancer.

	Why covid patients who could most benefit from paxlovid still aren’t getting it Evangelical minister Eddie Hyatt believes in the healing power of prayer but "also the medical approach." So on a February evening a week before scheduled prostate surgery, he had his sore throat checked out at an emergency room near his home in Grapevine, Texas.

	New analysis sheds light on cancer incidence and mortality trends in the UK Trends in cancer incidence and deaths in the United Kingdom (UK) among individuals aged between 35 and 69 years.

	Study: 20,000 men may have missed prostate cancer diagnosis due to the COVID-19 pandemic Prostate cancer diagnoses in 20,000 men could have been missed due to the COVID-19 pandemic, finds a new study from the University of Surrey and the University of Oxford.

	Research from NY highlights pollution as a key factor in rising cancer rates among youth Cancer incidence trends among adults in the New York State (NYS) and associations with common population-level exposures.

	MUTYH gene mutation linked to increased risk of various solid tumors A gene associated with colorectal cancer appears to also play a role in the development of other solid tumors, according to a study of over 350,000 patient biopsy samples conducted by researchers at the Johns Hopkins Kimmel Cancer Center, the Johns Hopkins Bloomberg School of Public Health and Foundation Medicine.

	Researchers aim to create AI-driven model for early detection of lung cancer risk Researchers are developing artificial intelligence which they hope will help to identify patients most at risk of lung cancer before symptoms have even appeared. A team from Nottingham Trent University and Nottingham University Hospitals NHS Trust aims to create an AI-driven model which can autonomously piece together subtle clues and signs in patients’ data to identify those at risk so that they can be investigated further.

	Special drug-pricing program boosts prostate cancer treatment adherence Prostate cancer patients receiving care at hospitals that are part of a special drug-pricing program were more likely to stick to their prescription drug therapy than patients at other hospitals, according to a study from researchers at the University of Michigan's Rogel Cancer Center and Institute for Healthcare Policy and Innovation.

	Combining MRI and blood tests to avoid unnecessary prostate biopsies MRI of the prostate, combined with a blood test, can help determine if a prostate lesion is clinically significant cancer, new research suggests.

	Multiomic approach boosts disease prediction accuracy beyond traditional methods Study highlights the significant enhancement in predicting common diseases like heart disease, diabetes, Alzheimer's, and prostate cancer by integrating polygenic risk scores (PRSs) and gut microbiome scores with conventional risk factors, showcasing the potential of multiomic approaches in personalized medicine.

	Men with advanced degrees and higher income more likely to receive better prostate cancer care Men with advanced degrees and higher income are more likely to receive certain care and treatment for prostate cancer.

	Advancing organoid culture: Innovative solutions for precision tissue engineering This article explores the role of Organoid Cultures in precision tissue engineering

Website: www.news-medical.net

Email: [email protected]

Telephone: +44 (0)161 457 7150

AZoNetwork UK Ltd.
NEO, 4th Floor
9 Charlotte Street, Manchester
M1 4ET, UK

Why did you receive this email?
You recently requested related information from us and asked to be notified of additional information.

Not interested anymore?
Unsubscribe or
Update Your Newsletter Subscriptions